
    
      A total of 24 evaluable patients will be enrolled in this study. The study randomly divided
      into three dose groups and HEC110114 tablets planned dose levels are 600, 800, and 1200 mg,
      sofosbuvir tablets planned dose levels are 400 mg .
    
  